Regulation of Actin Filament Dynamics and Stability: Potential Drug Targets and Biomarkers

Target Name: RPS2P1

NCBI ID: G140755

RPS2P1

Other Name(s): dJ64K7.1 | ribosomal protein S2 pseudogene 1 | RPS2_26_1696 | Ribosomal protein S2 pseudogene 1

Regulation of Actin Filament Dynamics and Stability: Potential Drug Targets and Biomarkers

The protein encoded by the gene dJ64K7.1 (RPS2P1) has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. RPS2P1 is a member of the RPS2 gene family, which is known for Its role in regulating the structure and function of actin filaments in cells. The loss of RPS2P1 function has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Disease-related functions of RPS2P1

RPS2P1 is involved in the regulation of actin filament dynamics and stability, which are critical for the proper functioning of cells. The loss of RPS2P1 has been observed to result in changes in actin filament stability and dynamics, leading to the mis regulation of various cellular processes..

One of the known functions of RPS2P1 is its role in the regulation of mitochondrial fusion and fission. During mitochondrial fusion and fission, RPS2P1 is involved in the regulation of the structure and dynamics of the actin filaments that mediate the fusion process. In addition, RPS2P1 is also involved in the regulation of the subsequent fission process, which is critical for the proper functioning of mitochondria.

Another function of RPS2P1 is its role in the regulation of cytoskeletal organization and dynamics. RPS2P1 is involved in the regulation of the stability and dynamics of the cytoskeleton, which is critical for the proper functioning of cells. The cytoskeleton provides structural support to cells, helps maintain cell shape, and plays a role in cell-cell interactions.

In addition to its role in regulating actin filament dynamics and cytoskeletal organization, RPS2P1 is also involved in the regulation of cell adhesion and migration. RPS2P1 is involved in the cell-cell adhesion, which is critical for the proper functioning of tissues and organs regulation . In addition, RPS2P1 is also involved in the regulation of cell migration, which is critical for the proper functioning of tissues and organs.

Drug targeting and biomarkers

The potential drug targets for RPS2P1 include inhibitors of its downstream targets, such as myosin ATPase (Myosin), which is involved in the regulation of actin filament dynamics and stability. In addition, inhibitors of RPS2P1 itself have also been shown to be effective in cell culture models of cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential drug targets, RPS2P1 is also a potential biomarker for various diseases. The loss of RPS2P1 function has been observed to result in changes in cellular processes that are critical for the proper functioning of cells. These changes can be detected using various biomarkers, such as nuclear tissue-specific RNA, which is involved in the regulation of cellular processes that are critical for the proper functioning of cells.

Conclusion

In conclusion, RPS2P1 is a protein that is involved in the regulation of actin filament dynamics and stability, cytoskeletal organization and dynamics, cell adhesion and migration, and cell migration. The loss of RPS2P1 function has been implicated in the development and progression of various diseases , including cancer, neurodegenerative diseases, and autoimmune disorders. In addition to its potential drug targets and biomarkers, RPS2P1 is also involved in the regulation of mitochondrial fusion and fission, which are critical for the proper functioning of cells. Further research is needed to fully understand the role of RPS2P1 in the regulation of cellular processes and its potential as a drug target or biomarker.

Protein Name: Ribosomal Protein S2 Pseudogene 1

The "RPS2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets